U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Pharmacoeconomic Review Report: tiotropium bromide monohydrate (Spiriva Respimat) for inhalation [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.

Cover of Pharmacoeconomic Review Report: tiotropium bromide monohydrate (Spiriva Respimat) for inhalation

Pharmacoeconomic Review Report: tiotropium bromide monohydrate (Spiriva Respimat) for inhalation [Internet].

Show details

Abbreviations

CADTH

Canadian Agency for Drugs and Technologies in Health

CDR

CADTH Common Drug Review

COPD

chronic obstructive pulmonary disease

ICS

inhaled corticosteroid

LABA

long-acting beta-2 agonist

LAMA

long-acting muscarinic antagonist

ODB

Ontario Drug Benefit

Tio H 18

tiotropium bromide dry powder inhalation device (Spiriva HandiHaler)

Tio R 5

tiotropium bromide Soft Mist Inhaler (Spiriva Respimat)

Copyright © 2015 Canadian Agency for Drugs and Technologies in Health.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK535467

Views

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...